Good Harbor Advisors’s Merck MRK Stock Holding History

Good Harbor Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$683K	Buy	5,318 +3,620	+213%	+$424K	0.67%	36
2026 Q1	$204K	Buy	+1,698	New	+$196K	0.22%	79

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Good Harbor Advisors's MRK Position: Q2 2026 in Review

Good Harbor Advisors increased its Merck (MRK) stake by 213% in Q2 2026, buying an estimated $424K and bringing the position to 5,318 shares worth $683K. The position accounts for 0.67% of the portfolio, ranked #36.

Good Harbor Advisors first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,815 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Good Harbor Advisors held 5,318 shares of Merck worth $683K as of Q2 2026.
Good Harbor Advisors bought 3,620 Merck shares in Q2 2026, an estimated $424K.
Merck made up 0.67% of Good Harbor Advisors's portfolio in Q2 2026, its #36 holding.
Good Harbor Advisors first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
3,815 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Good Harbor Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.